Computational tools for the analysis and visualization of multiple protein-ligand complexes

Journal of Molecular Graphics and Modelling

Volumn 24, Issue 3, 2005, Pages 186-194

  O'Brien, Sean E ^a,b,c   Brown, David G ^a   Mills, James E ^a   Phillips, Chris ^a   Morris, Gregg ^a,b  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b ACCELRYS INC   (United States)

^c Cylene Pharmaceuticals   (United States)

Author keywords

Binding mode; Factor Xa; HIV 1 reverse transcriptase; Ligand protein interaction; Surface visualization; X ray structure

Indexed keywords

COMPLEXATION; COMPUTATIONAL METHODS; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; MOLECULAR STRUCTURE; VIRUSES; VISUALIZATION;

BINDING MODE; FACTOR XA; HIV-1 REVERSE TRANSCRIPTASE; LIGAND-PROTEIN INTERACTION; SURFACE VISUALIZATION; X-RAY STRUCTURE;

PROTEINS;

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 10A INHIBITOR; LIGAND; RNA DIRECTED DNA POLYMERASE;

ARTICLE; CRYSTALLOGRAPHY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN INTERACTION; SURFACE PROPERTY; X RAY CRYSTALLOGRAPHY;

CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; COMPUTER-AIDED DESIGN; CRYSTALLOGRAPHY, X-RAY; DATABASES, PROTEIN; DRUG DESIGN; FACTOR XA; GENOMICS; HIV-1 REVERSE TRANSCRIPTASE; LIGANDS; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEINS; PROTEOMICS; REVERSE TRANSCRIPTASE INHIBITORS; SERINE PROTEINASE INHIBITORS; SOFTWARE; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PROPERTIES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 27144452534     PISSN: 10933263     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmgm.2005.08.003     Document Type: Article

References (27)

1. A.C. Anderson The process of structure-based drug design Chem. Biol. 10 2003 787 797
2. T.L. Blundell, H. Jhoti, and C. Abell High-throughput crystallography for lead discovery in drug design Nat. Rev. Drug Discov. 1 2002 45 54
3. V. Mountain Astex, structural genomix, and syrrx Chem. Biol. 10 2003 95 98
4. J. Greer, J.W. Erickson, J.J. Baldwin, and M.D. Varney Application of three-dimensional structures of protein target molecules in structure-based drug design J. Med. Chem. 37 1994 1035 1054
5. T.L. Blundell Structure-based drug design Nature 384 1996 S23 S26
6. H.M. Berman, J. Westbrook, Z. Feng, G. Gilliland, T.N. Bhat, H. Weissig, I.N. Shindyalov, and P.E. Bourne The protein data bank Nucleic Acids Res. 28 2000 235 242
7. E. De Clerq The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection Antiviral Res. 38 1998 153 179
8. B.G. Gazzard Efavirenz in the management of HIV infection Int. J. Clin. Pract. 53 1999 60 64
9. D. Richmanan, C.K. Shih, I. Lowry, J. Rose, and P. Prodanovich Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture Proc. Natl. Acad. Sci. 88 1991 11241 11245
10. R.F. Schinazi, B.A. Larder, and J.W. Mellors Mutations in retroviral genes associated with drug resistance Int. Viral News 4 1996 95 107
11. K.A. Sepkowitz AIDS - the first 20 years New Engl. J. Med. 344 2001 1764 1770
12. A.M. Doherty Annual Reports in Medicinal Chemistry 2003 Elsevier Press San Diego
13. D. Leung, G. Abbernante, and D.P. Fairlie Protease inhibitors: current status and future prospects J. Med. Chem. 43 2000 305 341
14. W.R. Ewing, H.W. Pauls, and A.P. Spada Progress in the design of inhibitors of coagulation factor Xa Drugs Future 24 1999 771 787
15. N.A. Prager, D.R. Abendschein, C.R. McKenzie, and P.R. Eisenberg Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots Circulation 92 1995 962 967
16. B. Kaiser Thrombin and factor Xa inhibitors Drugs Future 23 1998 423 436
17. S. Maignan, J.-P. Guilloteau, Y.M. Choi-Sledeski, M.R. Becker, and W.R. Ewing Molecular structures of human factor Xa complexed with ketopiperazine inhibitors: preference for a neutral group in the S1 pocket J. Med. Chem. 46 2003 685 690
18. Accelrys Inc., Cerius2, 4.91, San Diego, CA, 2004.
19. J. Bradshaw, Introduction to the Tversky similarity measure, Daylight UGM Meeting, Laguna Beach, CA, 1997.
20. A. Tversky Features of similarity Psych. Rev. 84 1977 327 352
21. P. Willett, J.M. Barnard, and G.M. Downs Chemical similarity searching J. Chem. Inf. Comp. Sci. 38 1998 983 996
22. Z. Deng, C. Chuaqui, and J. Singh Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions J. Med. Chem. 47 2004 337 344
23. N. Stiefl, and K. Baumann Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity technique J. Med. Chem. 46 2003 1390 1407
24. K. Hasegawa, S. Matsuoka, M. Arakawa, and K. Funatsu New molecular surface-based 3D-QSAR method using Kohonen neural network and 3-way PLS Comp. Chem. 26 2002 583 589
25. J. Polanski, and B. Walczak The comparative molecular surface analysis (COMSA): a novel tool for molecular design Comp. Chem. 24 2000 615 625
26. M. Hahn Receptor surface models. Part 1: definition and construction J. Med. Chem. 38 1995 2080 2090
27. Accelrys Inc., ViewerPro 5.7, San Diego, CA, 2004.